FULC
Price
$6.67
Change
-$0.15 (-2.20%)
Updated
Aug 18, 03:26 PM (EDT)
Capitalization
368.9M
86 days until earnings call
NLSP
Price
$2.57
Change
+$0.06 (+2.39%)
Updated
Aug 18, 03:40 PM (EDT)
Capitalization
12.32M
Interact to see
Advertisement

FULC vs NLSP

Header iconFULC vs NLSP Comparison
Open Charts FULC vs NLSPBanner chart's image
Fulcrum Therapeutics
Price$6.67
Change-$0.15 (-2.20%)
Volume$200
Capitalization368.9M
Nls Pharmaceutics
Price$2.57
Change+$0.06 (+2.39%)
Volume$100
Capitalization12.32M
FULC vs NLSP Comparison Chart in %
Loading...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NLSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FULC vs. NLSP commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a Hold and NLSP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (FULC: $6.82 vs. NLSP: $2.51)
Brand notoriety: FULC and NLSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 72% vs. NLSP: 74%
Market capitalization -- FULC: $368.9M vs. NLSP: $12.32M
FULC [@Biotechnology] is valued at $368.9M. NLSP’s [@Biotechnology] market capitalization is $12.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green whileNLSP’s FA Score has 0 green FA rating(s).

  • FULC’s FA Score: 1 green, 4 red.
  • NLSP’s FA Score: 0 green, 5 red.
According to our system of comparison, NLSP is a better buy in the long-term than FULC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 5 TA indicator(s) are bullish while NLSP’s TA Score has 5 bullish TA indicator(s).

  • FULC’s TA Score: 5 bullish, 5 bearish.
  • NLSP’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, FULC is a better buy in the short-term than NLSP.

Price Growth

FULC (@Biotechnology) experienced а +5.08% price change this week, while NLSP (@Biotechnology) price change was +17.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.78%. For the same industry, the average monthly price growth was +22.49%, and the average quarterly price growth was +23.13%.

Reported Earning Dates

FULC is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+8.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FULC($369M) has a higher market cap than NLSP($12.3M). FULC YTD gains are higher at: 45.106 vs. NLSP (18.957). NLSP has less debt than FULC: NLSP (1.63M) vs FULC (7.57M).
FULCNLSPFULC / NLSP
Capitalization369M12.3M3,000%
EBITDA-81.28MN/A-
Gain YTD45.10618.957238%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash214MN/A-
Total Debt7.57M1.63M463%
FUNDAMENTALS RATINGS
FULC: Fundamental Ratings
FULC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FULCNLSP
RSI
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
76%
Bullish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 6 days ago
88%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NLSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UNF173.63-1.09
-0.62%
Unifirst Corp
BFIN11.50-0.08
-0.69%
BankFinancial Corp
WSM203.23-2.21
-1.08%
Williams-Sonoma
GSBC59.17-0.88
-1.47%
Great Southern Bancorp
BFRG1.25-0.03
-2.34%
Bullfrog AI Holdings

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with ANNX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then ANNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
+3.33%
ANNX - FULC
40%
Loosely correlated
+2.52%
VRDN - FULC
40%
Loosely correlated
+0.54%
RARE - FULC
39%
Loosely correlated
N/A
MRNA - FULC
38%
Loosely correlated
+4.98%
BMRN - FULC
38%
Loosely correlated
-0.79%
More

NLSP and

Correlation & Price change

A.I.dvisor tells us that NLSP and MBIO have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NLSP and MBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NLSP
1D Price
Change %
NLSP100%
-3.83%
MBIO - NLSP
27%
Poorly correlated
-0.56%
COCP - NLSP
26%
Poorly correlated
+0.89%
SCNI - NLSP
26%
Poorly correlated
-12.64%
MESO - NLSP
25%
Poorly correlated
+2.46%
FULC - NLSP
24%
Poorly correlated
+3.33%
More